Compare Heron Therapeutics Inc (HRTX) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Standard Lithium Ltd — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while Standard Lithium Ltd trades at $2.27 (market cap $523.89M). The key difference: Standard Lithium Ltd is far larger — about 5.7× Heron Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| HRTX | SLI | |
|---|---|---|
Market Cap | $91.46M | $523.89M |
Sector | Health | Basic Materials |
52-Week High | $1.96 | $5.65 |
52-Week Low | $0.39 | $2.15 |
Enterprise Value | $189.36M | $383.09M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
